Amphastar Pharmaceuticals (AMPH) Research & Development (2013 - 2026)
Amphastar Pharmaceuticals (AMPH) posted Research & Development of $22.16 million for Q2 2026, up 10.4% from $20.08 million a year earlier but down 17.1% from the prior quarter.
Powered by 
Analysis
Amphastar Pharmaceuticals (AMPH) Research & Development (2013 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Research & Development at Amphastar Pharmaceuticals was $94.57 million, up 19.1% year-over-year; for FY2025, it was $85.84 million, up 16.1% from FY2024.
- Annual Research & Development shows a five-year compound annual growth rate of 5.0% (FY2020 to FY2025).
- In prior years, Amphastar Pharmaceuticals' Research & Development was $73.91 million in FY2024 (+0.2%), $73.74 million in FY2023 (-1.4%), $74.77 million in FY2022 (+22.7%) and $60.93 million in FY2021 (-9.4%).
- Quarterly Research & Development has run from a low of $10.76 million in Q3 2021 to a high of $26.74 million in Q1 2026 over five years.
- On a year-over-year basis, Research & Development has increased in each of the last six quarters, with growth averaging 15.6% over the last eight quarters.
- The strongest year-over-year quarter for Research & Development in the past five years was Q3 2022, with growth of 72.1%; the weakest was Q3 2021, with a decline of 39.0%.
- According to Business Quant data, Research & Development for the three prior quarters was $26.74 million (Q1 2026), $23.31 million (Q4 2025) and $22.35 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Amphastar Pharmaceuticals | 1.16 Bn | 23.86 Mn | 93.47 Mn | 22.16 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22.16 Mn |
| Mar 31, 2026 | 26.74 Mn |
| Dec 31, 2025 | 23.31 Mn |
| Sep 30, 2025 | 22.35 Mn |
| Jun 30, 2025 | 20.08 Mn |
| Mar 31, 2025 | 20.10 Mn |
| Dec 31, 2024 | 18.14 Mn |
| Sep 30, 2024 | 21.08 Mn |
| Jun 30, 2024 | 17.65 Mn |
| Mar 31, 2024 | 17.04 Mn |
| Dec 31, 2023 | 20.42 Mn |
| Sep 30, 2023 | 16.66 Mn |
| Jun 30, 2023 | 16.84 Mn |
| Mar 31, 2023 | 19.82 Mn |
| Dec 31, 2022 | 17.24 Mn |
| Sep 30, 2022 | 18.51 Mn |
| Jun 30, 2022 | 22.80 Mn |
| Mar 31, 2022 | 16.22 Mn |
| Dec 31, 2021 | 17.29 Mn |
| Sep 30, 2021 | 10.76 Mn |
API Access
Amphastar Pharmaceuticals Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=AMPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "AMPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=AMPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();